Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

Different strategies for treatment and prevention of Alzheimer’s disease (AD) are currently under investigation, including passive immunization with anti-amyloid β (anti-Aβ) monoclonal antibodies (mAbs). Here, we investigate the therapeutic potential of a novel type of Aβ-targeting agent based on an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Aging Neurosci
Autors principals: Boutajangout, Allal, Lindberg, Hanna, Awwad, Abdulaziz, Paul, Arun, Baitalmal, Rabaa, Almokyad, Ismail, Höidén-Guthenberg, Ingmarie, Gunneriusson, Elin, Frejd, Fredrik Y., Härd, Torleif, Löfblom, John, Ståhl, Stefan, Wisniewski, Thomas
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440316/
https://ncbi.nlm.nih.gov/pubmed/30967771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars